Skip to main content
Donald Landry, MD, Nephrology, New York, NY, New York-Presbyterian Hospital

DonaldW.LandryMDPhD

Nephrology • New York, NY

Samuel Bard Professor and Chair, Columbia University Physician-in-Chief, NewYork Presbyterian/CUMC

Request Appointment

Overview of Dr. Landry

Dr. Donald Landry is a nephrologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital and NewYork-Presbyterian/Columbia University Irving Medical Center. He received his medical degree from Columbia University Vagelos College of Physicians and Surgeons and has been in practice 34 years. Dr. Landry accepts several types of health insurance, listed below. He is one of 171 doctors at New York-Presbyterian Hospital and one of 62 doctors at NewYork-Presbyterian/Columbia University Irving Medical Center who specialize in Nephrology. He has more than 100 publications and over 500 citings.

Education & Training

  • New York Presbyterian Hospital (Columbia Campus)
    New York Presbyterian Hospital (Columbia Campus)Fellowship, Nephrology, 1985 - 1987
  • Massachusetts General Hospital
    Massachusetts General HospitalResidency, Internal Medicine, 1983 - 1985
  • Massachusetts General Hospital
    Massachusetts General HospitalInternship, Internal Medicine, 1983 - 1984
  • Columbia University Vagelos College of Physicians and Surgeons
    Columbia University Vagelos College of Physicians and SurgeonsClass of 1983
  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Fellowship, Nephrology

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 1985 - 2026
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Nephrology

Awards, Honors, & Recognition

  • Elected Member The American Society for Clinical Investigation, 1998

Publications & Presentations

PubMed

Abstracts/Posters

  • Strategy for Overcoming Crebbp and EP300 Mutations in Lymphoma: Development of First-in-Class HAT Activators
    Donald Landry, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

  • Development of First-in-Class Histone Acetyltransferase (HAT) Activators for Precision Targeting of Epigenetic Derangements in Lymphoma 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

  • Three Columbia Physicians Named to American Society for Clinical Investigation
    Three Columbia Physicians Named to American Society for Clinical InvestigationFebruary 14th, 2022
  • Cancer Center at 50
    Cancer Center at 50December 23rd, 2021
  • CUIMC Employees Share Their Vaccination Stories in Statewide Education Campaign
    CUIMC Employees Share Their Vaccination Stories in Statewide Education CampaignApril 8th, 2021
  • Join now to see all

Grant Support

  • High-Activity Mutants Of Cocaine Esterase For Treatment Of Drug AddictionNational Institute On Drug Abuse2008–2011
  • Core--ChemistryNational Heart, Lung, And Blood Institute2007–2011
  • Metabolism In Heart Failure Translational Research CenterNational Heart, Lung, And Blood Institute2009–2010
  • Cocaine Catalytic Antibodies: Novel Technology For Demand ReductionNational Center For Research Resources1999

Hospital Affiliations

Insurance Accepted

  • Aetna Choice POS II
    Aetna HMO
    HIP of New York - Select PPO
    Multiplan PHCS PPO
    Multiplan PPO
    Oxford Health Freedom
    Oxford Health Liberty
    United Healthcare - Direct Choice Plus POS
    United Healthcare - Direct Options PPO
  • Please verify your coverage with the provider's office directly when scheduling an appointment

Dr. Donald Landry, Dr. Donald Landry, MD, Dr. D Landry, Dr. Donald W. Landry